Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Complement and coagulation cascades	4/85	2.285237964507944e-06	9.369475654482569e-05	65.73662551440329	-156.86991400393836	F2;F5;PROC;SERPINC1
KEGG_2021_Human	One carbon pool by folate	1/20	0.02449807059329832	0.15766209944928727	47.07017543859649	-23.030592878842292	MTHFR
KEGG_2021_Human	Arginine biosynthesis	1/22	0.026917919418171	0.15766209944928727	42.576719576719576	-21.34946103825324	GLUL
KEGG_2021_Human	Nitrogen metabolism	1/17	0.020858141730383632	0.15766209944928727	55.916666666666664	-26.157848827787358	GLUL
KEGG_2021_Human	Necroptosis	2/159	0.015618487202540639	0.15766209944928727	12.597133757961783	-17.083187709957596	GLUL;JAK2
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.15766209944928727	6.12012987012987	-11.164029011261546	EPO;F2;JAK2
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.15766209944928727	12.35625	-16.748364182562245	EPO;JAK2
KEGG_2021_Human	Glyoxylate and dicarboxylate metabolism	1/30	0.03654338399736008	0.1872848429864704	30.800766283524904	-16.574318247175444	GLUL
KEGG_2021_Human	Alanine, aspartate and glutamate metabolism	1/37	0.04489527895199197	0.2045229374479634	24.790123456790123	-13.876145105511855	GLUL
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.23290743356217689	5.480113636363637	-6.479364551821025	EPO;JAK2
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.23290743356217689	10.075757575757576	-6.080768259179883	JAK2
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.23290743356217689	13.071895424836601	-7.854937277937848	JAK2
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.23290743356217689	8.345911949685535	-4.994589105830365	JAK2
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.23290743356217689	9.739926739926739	-5.8737398650795125	JAK2
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.23290743356217689	12.880837359098228	-7.74542097629872	JAK2
KEGG_2021_Human	GABAergic synapse	1/89	0.10492639565254669	0.23290743356217689	10.075757575757576	-6.080768259179883	GLUL
KEGG_2021_Human	Glutamatergic synapse	1/114	0.13256015588280526	0.23290743356217689	7.822025565388397	-4.655477238055189	GLUL
KEGG_2021_Human	Cholinergic synapse	1/113	0.1314697223892576	0.23290743356217689	7.892857142857143	-4.701617375992292	JAK2
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.23290743356217689	8.189300411522634	-4.893732148578802	EPO
KEGG_2021_Human	Hematopoietic cell lineage	1/99	0.11607356788707196	0.23290743356217689	9.036281179138323	-5.434068642481248	EPO
KEGG_2021_Human	Platelet activation	1/124	0.14339691916847833	0.23290743356217689	7.177055103884372	-4.231046804704064	F2
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.23290743356217689	7.964964964964965	-4.748494648054986	JAK2
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.23290743356217689	11.68421052631579	-7.04872976578505	JAK2
KEGG_2021_Human	Lysosome	1/128	0.14769739689308778	0.23290743356217689	6.94750656167979	-4.078087345546839	SLC17A5
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.23290743356217689	8.94388327721661	-5.375723879218761	JAK2
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.23290743356217689	7.4858757062146895	-4.435243302362896	JAK2
KEGG_2021_Human	Phospholipase D signaling pathway	1/148	0.16890973234869874	0.24733210808202313	5.987150415721844	-3.427000500776257	F2
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.24733210808202313	6.2018779342723	-3.57415842622014	JAK2
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.25939481146091453	5.456866804692892	-3.0596637281364782	JAK2
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.2639511082506169	4.896958410924891	-2.6658400097237527	JAK2
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.2639511082506169	4.5823152995927865	-2.441961042053517	JAK2
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.2639511082506169	4.462585034013605	-2.3563138595912863	F2
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.2639511082506169	4.55787037037037	-2.4244944960200487	JAK2
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.2639511082506169	5.131254061078622	-2.8313674486945275	JAK2
KEGG_2021_Human	Lipid and atherosclerosis	1/215	0.23655445762047492	0.2727228055873525	4.077881619937695	-2.079575623138921	JAK2
KEGG_2021_Human	Regulation of actin cytoskeleton	1/218	0.2394639268571876	0.2727228055873525	4.019969278033794	-2.037730229066884	F2
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.280043367919712	3.7696007696007694	-1.8563524399324505	F2
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.280043367919712	3.6554621848739495	-1.7734497985532327	JAK2
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.3267471795774438	2.9380196523053668	-1.2513063817932166	EPO
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.35926003130799733	2.5254901960784313	-0.9533164047874388	F2
KEGG_2021_Human	Herpes simplex virus 1 infection	1/498	0.4709527127104428	0.4709527127104428	1.6926000447127207	-0.379898711570649	JAK2
